COVID-19 and the Path to Immunity , JAMA (published 11th September 2020)

This Viewpoint outlines what is known about acute and long-term B-cell, antibody, and T-cell responses to SARS-CoV-2 infection and explains how each are implicated in vaccine candidates likely to be effective and durably protective again COVID-19.

Source: Current Awareness Service for Health (CASH) - September 15, 2020 Category: Consumer Health News Source Type: news